Prospective Study of Vitamin D and MS Risk in African Americans

非裔美国人维生素 D 和多发性硬化症风险的前瞻性研究

基本信息

  • 批准号:
    10242084
  • 负责人:
  • 金额:
    $ 42.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-15 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY In spite of progress in treatment and promising new drugs multiple sclerosis (MS) continues to be a chronic progressive disease with a high impact on the quality of life of those affected, their families, and society. Further, MS incidence is increasing among US Blacks and among women of all races in several regions in the world. These rapid increases cannot be explained by genetic factors, and strongly suggest that environmental factors, possibly modifiable, are contributing to determine MS risk. Vitamin D is likely to be one of these factors, but questions remain on the role of vitamin D in MS particularly among blacks. Ten years ago, we published a landmark paper reporting that young healthy non-Hispanic white adults with higher serum levels of 25- hydroxyvitamin D (25(OH)D) had a 62% lower risk of developing MS than those with lower levels. This finding, which has been later confirmed in multiple studies, has major public health implications because it supports the notion that the ongoing increase in MS incidence could be halted or reversed by increasing vitamin D levels. An important limitation, however, is that this inverse association between vitamin D and MS risk cannot be generalized to blacks. Further, it remains unclear whether vitamin D levels important only during childhood and adolescence or also during adult life, and whether there are differences between men and women in the vitamin D levels needed to prevent MS. Answering these questions is critical to be able to translate the research findings into sound and effective public health interventions. The proposed study relies on the unique data and blood samples collected from over 10 million individuals during their active duty within the US military and over 60 million serum samples stored in the Department of Defense Serum Repository. The availability of multiple blood samples from each individual prior to MS onset allows an accurate estimate of long term average 25(OH)D levels, and the diverse composition of the study population will allow for the first time to obtain accurate estimates of the relation between vitamin D and MS risk among US blacks, to determine whether the relation between 25(OH)D and MS risk is modified by age or gender, and to explore gene-environment interactions that have potentially important public health implications.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALBERTO ASCHERIO其他文献

ALBERTO ASCHERIO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALBERTO ASCHERIO', 18)}}的其他基金

Biomarkers and risk factors for prodromal Parkinson's disease and its progression
帕金森病前驱期及其进展的生物标志物和危险因素
  • 批准号:
    10594036
  • 财政年份:
    2022
  • 资助金额:
    $ 42.66万
  • 项目类别:
Biomarkers and risk factors for prodromal Parkinson's disease and its progression
帕金森病前驱期及其进展的生物标志物和危险因素
  • 批准号:
    10417436
  • 财政年份:
    2022
  • 资助金额:
    $ 42.66万
  • 项目类别:
Serological profiling of the human virome and ALS risk in a military population
军人人群中人类病毒组和 ALS 风险的血清学分析
  • 批准号:
    10252746
  • 财政年份:
    2020
  • 资助金额:
    $ 42.66万
  • 项目类别:
Serological profiling of the human virome and ALS risk in a military population
军人人群中人类病毒组和 ALS 风险的血清学分析
  • 批准号:
    10438144
  • 财政年份:
    2020
  • 资助金额:
    $ 42.66万
  • 项目类别:
Serological profiling of the human virome and ALS risk in a military population
军人人群中人类病毒组和 ALS 风险的血清学分析
  • 批准号:
    10117845
  • 财政年份:
    2020
  • 资助金额:
    $ 42.66万
  • 项目类别:
Prospective study of vitamin D and MS risk in African Americans
非裔美国人维生素 D 和多发性硬化症风险的前瞻性研究
  • 批准号:
    10018657
  • 财政年份:
    2018
  • 资助金额:
    $ 42.66万
  • 项目类别:
Metabolomics and risk of Parkinson's Disease
代谢组学和帕金森病的风险
  • 批准号:
    9313961
  • 财政年份:
    2015
  • 资助金额:
    $ 42.66万
  • 项目类别:
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
维生素 D、EB 病毒感染、吸烟和多发性肺疾病的风险
  • 批准号:
    8228025
  • 财政年份:
    2011
  • 资助金额:
    $ 42.66万
  • 项目类别:
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
维生素 D、EB 病毒感染、吸烟和多发性肺疾病的风险
  • 批准号:
    8449146
  • 财政年份:
    2011
  • 资助金额:
    $ 42.66万
  • 项目类别:
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
维生素 D、EB 病毒感染、吸烟和多发性肺疾病的风险
  • 批准号:
    8084442
  • 财政年份:
    2011
  • 资助金额:
    $ 42.66万
  • 项目类别:

相似海外基金

Plasma 25-Hydroxyvitamin D Concentration and Incident Risk of Dementia: a Case-cohort Study
血浆 25-羟基维生素 D 浓度和痴呆症事件风险:病例队列研究
  • 批准号:
    23K19881
  • 财政年份:
    2023
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Association between serum 25-hydroxyvitamin D and endothelium dysfunction in Japanese population
日本人群血清 25-羟基维生素 D 与内皮功能障碍之间的关联
  • 批准号:
    19K21451
  • 财政年份:
    2018
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
A prospective study about association between 25-hydroxyvitamin D and cognitive decline and development of lifestyle-related diseases.
一项关于 25-羟基维生素 D 与认知能力下降和生活方式相关疾病发展之间关系的前瞻性研究。
  • 批准号:
    17K09121
  • 财政年份:
    2017
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Direct effects of 25-hydroxyvitamin D on renal fibrosis
25-羟基维生素 D 对肾纤维化的直接影响
  • 批准号:
    26461227
  • 财政年份:
    2014
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Pooled Analysis of 25-hydroxyvitamin D and Colorectal Cancer Survival
25-羟基维生素 D 与结直肠癌生存的汇总分析
  • 批准号:
    8773987
  • 财政年份:
    2014
  • 资助金额:
    $ 42.66万
  • 项目类别:
C-3 alpha epimer of 25-hydroxyvitamin D origin and effects on growing bone
25-羟基维生素 D 来源的 C-3 α 差向异构体及其对骨骼生长的影响
  • 批准号:
    447751-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 42.66万
  • 项目类别:
    University Undergraduate Student Research Awards
Health service utilization, vitamin D supplementation and 25-hydroxyvitamin D levels in young children
幼儿保健服务利用、维生素 D 补充和 25-羟基维生素 D 水平
  • 批准号:
    307836
  • 财政年份:
    2013
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Studentship Programs
C-3 alpha epimer of 25-hydroxyvitamin D origin and effects on growing bone
25-羟基维生素 D 来源的 C-3 α 差向异构体及其对骨骼生长的影响
  • 批准号:
    447773-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 42.66万
  • 项目类别:
    University Undergraduate Student Research Awards
Amelioration of Vesicant-Induced Skin Injury by High Dose 25-Hydroxyvitamin D
高剂量 25-羟基维生素 D 改善出疱剂引起的皮肤损伤
  • 批准号:
    8722316
  • 财政年份:
    2012
  • 资助金额:
    $ 42.66万
  • 项目类别:
Amelioration of Vesicant-Induced Skin Injury by High Dose 25-Hydroxyvitamin D
高剂量 25-羟基维生素 D 改善出疱剂引起的皮肤损伤
  • 批准号:
    8545673
  • 财政年份:
    2012
  • 资助金额:
    $ 42.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了